T2 Biosystems, Inc. 4
4 · T2 Biosystems, Inc. · Filed Aug 14, 2014
Insider Transaction Report
Form 4
Cima Michael J.
Director
Transactions
- Conversion
Common Stock
2014-08-12+2,548→ 179,018 total - Purchase
Common Stock
2014-08-12$11.00/sh+2,000$22,000→ 181,018 total - Conversion
Series E Convertible Preferred Stock
2014-08-12−4,332→ 0 totalExercise: $0.00→ Common Stock (2,548 underlying)
Footnotes (1)
- [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.